Comprehensive Opioid, Stimulant, and Substance Abuse Site-based Program

Opioid misuse in the United States has become a problem of epidemic proportions.  To combat this misuse and prevent overdoses, the Madison County Sheriff’s Office Offender Reentry Program Team is requesting $998,934 over a 36 month period, from the Bureau of Justice Assistance, under the Comprehensive Opioid, Stimulant, Substance Abuse Site-based Program, Category 1 to implement a medication assisted treatment (MAT) program in the jail.  Upon receiving this grant the entity will go to funding MAT, evidence-based substance use disorder treatment related to opioids, as well as harm reduction activities and recovery support services.  The Madison County Sheriff’s Office Offender Reentry Program Team’s goal is to reduce the impact of illicit opioids, stimulants, and other substances on individuals and communities by incorporating recommendations from the CDC’s evidence based strategies for preventing opioid overdose and substance use related harm.  The program will provide injectable buprenorphine, an evidence based MAT to twenty (20) incarcerated individuals with an opioid use disorder per month and the remaining individuals will be inducted and/or maintained on other forms of approved MAT treatment.  To achieve these goals, the Offender Reentry Team Program Team will create and implement the following objectives and outcomes:
1)  Develop a working relationship with BJA-support COSSAP training and technical assistance (TTA) providers including ongoing coaching and dialogue as well as support, peer-to-peer dialogue and training, knowledge diffusion products, grantee learning communities, dissemination of best practice and lessons learned a.  Create and send reports to stakeholders quarterly
2)  Create a MAT program a.  Provide education to 100% staff b.  20 high-risk individuals will be inducted and/or maintained monthly into MAT on injectable buprenorphine and the remaining individuals will be inducted and/or maintained on other forms of approved MAT treatment
3)  Reduce opioid abuse and overdose deaths/lower arrest rates and court cases a.  20 high-risk individuals will be inducted and/or maintained monthly into MAT on injectable buprenorphine and the remaining individuals will be inducted and/or maintained on other forms of approved MAT treatment a.  100% of inducted individuals will attend individual and/or group therapy b.  100% of inducted individuals will receive training and be issued naloxone upon release
4)  Develop stronger relationships with outpatient MAT providers in establishing and/or maintaining communication a.  100% of inducted individuals will be referred to post-release MAT services